About
The Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) provides research funding and support for basic and clinical research in the areas of type 1 and type 2 diabetes and other metabolic disorders, including cystic fibrosis; endocrinology and endocrine disorders; obesity, neuroendocrinology, and energy balance; and development, metabolism, and basic biology of liver, fat, and endocrine tissues. DEM also provides funding for the training and career development of individuals committed to academic and clinical research careers in these areas.
Leadership
William Cefalu, M.D.
Director, Division of Diabetes, Endocrinology, & Metabolic Diseases
Corinne M. Silva, Ph.D.
Deputy Director: Division of Diabetes, Endocrinology, & Metabolic Diseases